Clinical Trial Update: A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating sequential antimetabolite induction, high-dose alkylating-agent consolidation with peripheral blood progenitor cell support, foll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Breast Neoplasms | Phase 2 | Status: COMPLETED